Interval cytoreduction
-
The objective of this study was to externally validate the KELIM (rate of elimination of CA-125) score in patients with high-grade serous ovarian cancer (HGSC) undergoing NACT and explore its relation to the completeness of IDS and survival.
8p vishanshan 27-06-2024 2 1 Download
-
The aim of the study is to investigate the clinical features and surgical outcomes of ureteral reconstruction during primary, interval and secondary cytoreductive surgery for ovarian cancer.
9p vileonardodavinci 23-12-2023 2 2 Download
-
To evaluate the impact of intraoperative hypotension and hemodynamic instability on survival out‑ comes in patients with high-grade serous ovarian carcinoma (HGSOC). Methods: We retrospectively identified patients with HGSOC, who underwent primary or interval debulking surgery between August 2013 and December 2019. We collected anesthesia-related variables, including the arterial blood pressure measurements (at 1-min intervals) during the surgery of patients.
12p vialfrednobel 23-12-2023 8 3 Download
-
The mainstay of endometrial cancer treatment is surgical resection of tumors and postoperative adjuvant treatment is recommended if necessary. However, there is no consensus on the management of unresectable metastatic endometrial cancer.
10p visusanwojcicki 28-06-2022 11 3 Download
-
As we all know, patients with epithelial ovarian carcinoma have poor prognosis and high recurrence rate. It is critical and challenging to screen out the patients with high risk of recurrence.
9p vijisoo2711 30-09-2020 13 1 Download
-
The oncologic safety of allogeneic blood transfusion in ovarian cancer patients is unknow. We sought to determine the prevalence and oncologic safety of perioperative allogeneic blood transfusion during interval cytoreduction surgery among women receiving neoadjuvant chemotherapy for ovarian cancer.
8p vimanila2711 25-06-2020 11 0 Download